| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.86B | 86.50B | 81.10B | 64.66B | 52.24B | 50.79B |
| Gross Profit | 23.39B | 22.39B | 22.16B | 17.42B | 14.32B | 12.74B |
| EBITDA | 7.70B | 8.13B | 8.90B | 8.32B | 6.16B | 5.32B |
| Net Income | 2.48B | 4.07B | 6.23B | 4.40B | 3.63B | 3.35B |
Balance Sheet | ||||||
| Total Assets | 108.94B | 115.62B | 101.56B | 90.08B | 80.02B | 79.19B |
| Cash, Cash Equivalents and Short-Term Investments | 17.60B | 17.11B | 13.40B | 11.88B | 13.53B | 16.80B |
| Total Debt | 18.54B | 24.36B | 16.12B | 16.51B | 16.61B | 17.71B |
| Total Liabilities | 53.49B | 59.20B | 48.92B | 44.55B | 38.74B | 41.57B |
| Stockholders Equity | 55.06B | 56.03B | 52.31B | 45.18B | 40.98B | 37.34B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.83B | -501.00M | 407.00M | -363.00M | 1.98B |
| Operating Cash Flow | 0.00 | -668.00M | 2.86B | 1.25B | 3.13B | 4.37B |
| Investing Cash Flow | 0.00 | -1.56B | 424.00M | -1.28B | -4.85B | -1.61B |
| Financing Cash Flow | 0.00 | 5.85B | -3.31B | -2.19B | -2.13B | -2.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥53.00B | 12.82 | ― | 3.47% | 13.90% | 6.51% | |
76 Outperform | ¥41.43B | 11.21 | ― | 3.32% | 18.47% | 64.23% | |
76 Outperform | ¥53.40B | 10.64 | ― | 2.79% | 2.85% | 3.17% | |
72 Outperform | ¥154.53B | 13.19 | 10.28% | 2.77% | 2.74% | 7.86% | |
70 Outperform | ¥67.96B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
70 Outperform | ¥134.62B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |